Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 5
|
pp. 7549–7569
Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease
Back to article
Figure 8
(8 of 9)
−
100%
+
Figure 8.
Forest plot of the expression of BDNF for the ginsenosdie-Rg1 group versus a control group.
Figure 8 — Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease | Aging
